Juventas Therapeutics

    OverviewSuggest Edit

    Juventas Therapeutics is a biotechnology company developing non-viral gene therapies. It offers JVS-100, a non-viral gene therapy that expresses stromal cell-derived factor-1, or SDF-1, a naturally occurring signaling protein recruiting the body’s own stem cells and promoting tissue repair in a range of disease states.
    TypePrivate
    Founded2007
    Websitejuventasinc.com

    Latest Updates

    Employees (est.) (Apr 2020)6

    Juventas Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2007
    Show all financial metrics

    Juventas Therapeutics Online and Social Media Presence

    Embed Graph

    Juventas Therapeutics Frequently Asked Questions

    • When was Juventas Therapeutics founded?

      Juventas Therapeutics was founded in 2007.

    • How many employees does Juventas Therapeutics have?

      Juventas Therapeutics has 6 employees.

    • Who are Juventas Therapeutics competitors?

      Competitors of Juventas Therapeutics include Emmaus Life Sciences, Sarepta Therapeutics and Rocket Pharmaceuticals.